Millennium Pharmaceuticals' Series A - II Round

Millennium Pharmaceuticals raised a round of funding on January 01, 1996.

Millennium is a biopharmaceutical company based in Cambridge, Mass, that markets VELCADE, a cancer product, and has a robust clinical development pipeline of product candidates. Millennium research, d…

Articles about Millennium Pharmaceuticals' Series A - II Round: